Dr. Randy Barton: Nanotechnology On A Commercial Scale
NanoViricides is using nanoscale materials and processes licensed from TheraCour Pharma, Inc. The company’s novel class of drug candidates is designed to specifically attack enveloped virus particles and dismantle them. Applications include treatment for H5N1 bird flu, seasonal influenza, HIV, Epidemic Kerato-Conjunctivitis, hepatitis C, rabies, dengue fever, and Ebola virus. Topics to be discussed include:
* Nanotechnology applications * Current outcomes data * How nanoscale pays big dividends in regard to outcomes
Dr. Randy Barton Chief Scientific Officer NanoViricides Incorporated
Market Data 
Markets 
